Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2026
Active Middle Ear Implantation for Sensorineural Hearing Loss: A Systematic Review and Meta-Analysis.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shapira Udi, Lifshitz Tal, Muhanna Nidal, Ungar Omer J
Аннотация
OBJECTIVE: To evaluate the audiological outcomes and safety profile of the Vibrant Soundbridge middle ear implant in patients with moderate-to-severe sensorineural hearing loss. Databases reviewed: PubMed, Embase, Google Scholar, and the enrolled papers' reference lists.
METHODS: A systematic literature review was performed according to Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. The database search yielded 194 articles, of which 48 underwent full-text review. The extracted data included age, sex, length of follow-up period and functional hearing gain.
RESULTS: Twenty-three studies (917 ears) were included in the qualitative synthesis, of which 16 (648 ears) were suitable for quantitative meta-analysis. The mean (SD) preoperative pure-tone average was 56.69 (4.27) dB hearing level. The pooled mean functional gain was 24.29 dB (95% CI: 20.09-28.49; P<0.01) hearing level. There was high interstudy heterogeneity (I²=99%). The overall complication rate over a mean follow-up period of 23.2 months was 8.3%, and the revision surgery rate over the same follow-up period was 6.2%. Internal device failure occurred in 1.7% (n=7/413) cases.
CONCLUSION: The Vibrant Soundbridge provided significant functional hearing gain and demonstrated a favorable safety profile in patients with moderate-to-severe sensorineural hearing loss. It affords a promising alternative for individuals who do not benefit from conventional hearing aids.
METHODS: A systematic literature review was performed according to Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. The database search yielded 194 articles, of which 48 underwent full-text review. The extracted data included age, sex, length of follow-up period and functional hearing gain.
RESULTS: Twenty-three studies (917 ears) were included in the qualitative synthesis, of which 16 (648 ears) were suitable for quantitative meta-analysis. The mean (SD) preoperative pure-tone average was 56.69 (4.27) dB hearing level. The pooled mean functional gain was 24.29 dB (95% CI: 20.09-28.49; P<0.01) hearing level. There was high interstudy heterogeneity (I²=99%). The overall complication rate over a mean follow-up period of 23.2 months was 8.3%, and the revision surgery rate over the same follow-up period was 6.2%. Internal device failure occurred in 1.7% (n=7/413) cases.
CONCLUSION: The Vibrant Soundbridge provided significant functional hearing gain and demonstrated a favorable safety profile in patients with moderate-to-severe sensorineural hearing loss. It affords a promising alternative for individuals who do not benefit from conventional hearing aids.